Financing, Equity Capital Markets
Ocular Therapeutix, Inc.
01/18
|
$37.4 Million
Âé¶¹´«Ã½ served as sole bookrunner for Ocular Therapeutix, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sector
Sub-Sector
Biopharma